Advertisements


We are Sorry, This Page doesn't Exist


Analysts Defend Esperion As Shares Sell Off Sharply

Esperion Therapeutics Inc (NASDAQ: ESPR) stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. Latest Ratin.....»»

Category: blogSource: benzingaMay 3rd, 2018

Esperion Shares Plunge After Cholesterol-Lowering Drug"s Phase 3 Results Stir Safety Concerns

Esperion Therapeutics Inc (NASDAQ: ESPR) shares are in free fall Wednesday after the company repor.....»»

Category: earningsSource: benzingaMay 2nd, 2018

Esperion Therapeutics stock price target cut to $75 from $90 at UBS

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 16th, 2018

Is Esperion Therapeutics Inc. a Buy on the Dip?

The recent safety scare might not be as bad as feared. Does that make the highly-focused biotech stock a buy now?.....»»

Category: topSource: foxnewsMay 8th, 2018

Why Esperion Therapeutics Shares Are Crashing (Again!) Today

A key rating change is adding to investor's pessimism......»»

Category: topSource: foxnewsMay 3rd, 2018

Top Analyst Upgrades and Downgrades: Andeavor, Discovery, Estee Lauder, Esperion Therapeutics, Hologic, Nvidia, Yum Brands and More

The top analyst upgrades, downgrades and other research calls from Thursday include Andeavor, Discovery, Estee Lauder, Esperion Therapeutics, Hologic, Nvidia and Yum Brands......»»

Category: blogSource: 247wallstMay 3rd, 2018

Mid-Day Market Update: Nanometrics Rises On Earnings Beat; Esperion Therapeutics Shares Drop

Midway through trading Wednesday, the Dow traded down 0.14 percent to 24,066.62 while the NASDAQ climbed 0.01 percent to 7,130.96. The S&P also fell, dropping 0.20 percent to 2,649.41. read more.....»»

Category: blogSource: benzingaMay 2nd, 2018

Esperion Therapeutics Inc Shares Plunge on Cholesterol Drug Safety Concerns

InvestorPlace - Stock Market News, Stock Advice & Trading Tips .....»»

Category: topSource: investorplaceMay 2nd, 2018

Can Esperion Therapeutics Go the Distance After This Report?

Esperion Therapeutics released its first-quarter financial results and a business update before the markets opened on Wednesday......»»

Category: blogSource: 247wallstMay 2nd, 2018

Esperion Shares Plunge After Cholesterol-Lowering Drug"s Phase 3 Results Stir Safety Concerns

Esperion Therapeutics In.....»»

Category: blogSource: benzingaMay 2nd, 2018

Esperion shares plummet 20% on late-stage trial results

Esperion Therapeutics Inc. sha.....»»

Category: topSource: marketwatchMay 2nd, 2018

Esperion shares halted on positive late-stage trial results

Esperion Therapeutics Inc. shares were halted in premarket trade Wednesday on news of positive results for a late-stage clinical trial of its cholesterol-lowering medication. The phase 3 trial, which enrolled .....»»

Category: topSource: marketwatchMay 2nd, 2018

Rising oil prices help ground U.S. airline stocks; could make them cheap

NEW YORK (Reuters) - Shares of U.S. airlines have been depressed by rising oil prices this year, but their descent to relatively cheap levels could position them for takeoff......»»

Category: topSource: reuters1 min. ago

Voyager Therapeutics (VYGR) Presents At 21st Annual Meeting of the American Society of Gene and Cell Therapy - Slideshow

Voyager Therapeutics (VYGR) Presents At 21st Annual Meeting of the American Society of Gene and Cell Therapy - Slideshow.....»»

Category: topSource: seekingalpha15 min. ago

Leap Therapeutics (LPTX) DKN-01 Program Update - Slideshow

Leap Therapeutics (LPTX) DKN-01 Program Update - Slideshow.....»»

Category: topSource: seekingalpha1 hr. 15 min. ago

MabVax Therapeutics says prior audits should no longer be relied upon

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 45 min. ago

MabVax Therapeutics Holdings trading resumes

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 45 min. ago

MabVax Therapeutics Holdings trading halted, news pending

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 45 min. ago

Agile Therapeutics price target lowered to $3 from $7 at RBC Capital

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 45 min. ago

Aratana Therapeutics appoints Craig Barbarosh, Lowell Robinson to board

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall1 hr. 45 min. ago